The latest analysis from a Toronto‑based hospital network reveals a rapidly expanding opioid crisis that is largely invisible in public discourse. Approximately one in 350 older Ontarians now meets the criteria for opioid use disorder (OUD), a figure that marks an 81 % jump since 2017. Between 2017 and 2025, the number of individuals aged 55 and over seeking treatment for OUD doubled, climbing from 7 116 to 15 231 cases. Deaths linked to opioids in this age group have also risen, moving from 1.1 per 100 000 in 2013 to 1.8 per 100 000 in 2024. The report, produced by Unity Health and the Ontario Drug Policy Research Network, warns that the problem is both under‑recognised and evolving, with many seniors now grappling with health‑care needs that stem from dependencies formed decades earlier.
The Scale of the Problem
The data paints a stark picture of growth. The prevalence of OUD among seniors has escalated dramatically, with the overall rate now standing at roughly 0.29 % of the older population. This surge is not merely a statistical anomaly; it reflects a cohort that began receiving high levels of opioid prescriptions in the 1990s and early 2000s. As prescription patterns shifted in the 2010s, many of these individuals transitioned to illicit supplies, creating a hidden wave of dependency that is only now being captured by health‑service records.
A short but telling observation: the climb is consistent across both treatment admissions and related harms.
Key Findings and Trends
Commonly prescribed opioids such as hydromorphone, oxycodone, codeine, morphine and methadone dominate the medication landscape for older adults. The report highlights that 78 % of OUD‑related deaths occur in private residences, underscoring the isolation many seniors face when managing their medication. Epidemiologist Tara Gomes, the lead author, notes that better awareness and screening may partially explain the rise in identified cases. However, she also points to the long‑term consequences of early‑era prescribing practices, observing that a generation that developed dependence decades ago is now entering an age where metabolism of drugs slows, increasing vulnerability to adverse outcomes.
The data also reveals a concerning trend in mortality. Opioid‑related deaths among those over 55 have risen steadily, with the rate climbing from 1.1 to 1.8 per 100 000 over more than a decade. This upward trajectory coincides with a parallel increase in emergency‑department visits linked to drug interactions, a risk amplified by polypharmacy common in older patients.
Impact on Health and Care
Physicians such as Dr Samir Sinha from the National Institute on Ageing stress that ageing bodies process medications less efficiently, making seniors more susceptible to overdose and adverse reactions. He urges clinicians to explore “all other options” before reaching for opioids to manage chronic pain, recommending alternatives like non‑opioid medication, massage therapy or structured exercise programmes.
Long‑term care facilities face additional challenges. Gomes highlights chronic understaffing, noting that many homes lack the capacity to monitor doses or intervene when complications arise. This staffing shortfall can leave residents—especially those with complex OUD needs—without the supervision required to ensure safety.
The broader societal perception also lags behind the reality. Sinha points out that political and clinical narratives often centre on younger people who misuse drugs illicitly, overlooking the senior cohort that is legally prescribed opioids yet still encounters serious problems.
Calls for Policy and Prevention
The Unity Health report is part of a growing body of evidence urging a re‑evaluation of how opioid policies address older adults. Stakeholders are calling for targeted screening tools tailored to geriatric populations, enhanced training for care home staff, and public‑awareness campaigns that challenge the stigma surrounding senior drug use. Moreover, policymakers are urged to fund integrated care models that combine pain management, mental‑health support and addiction services specifically designed for this age group.
The Ontario Drug Policy Research Network concludes that “our findings will bring to light the nature of this often overlooked and evolving crisis among older adults and help inform programmes and policies to prevent deaths in the future.”
Why it Matters
The escalating opioid crisis among seniors is not a peripheral issue; it threatens the health of a rapidly ageing population and strains an already burdened health‑care system. As the baby‑boom generation moves into older age brackets, the societal and economic costs of untreated or mismanaged OUD will only intensify. Addressing this hidden epidemic now—through better screening, tailored treatment options, and policy reforms—will be essential to prevent a future where opioid‑related harm becomes an accepted feature of ageing in Ontario and beyond.
